Companies → WELLBIOTEC CO.,LTD
Save to list
Remove

WELLBIOTEC CO.,LTD

South Korea, Seoul
Description
by AI
WELLBIOTEC is a leading biotech Contract Development and Manufacturing Organization (CDMO) with manufacturing sites in South Korea, USA and Europe and Research Center in South Korea. - 20+ years of experience in the development and production of new biological drugs and biosimilars - Comprehensive suite of capabilities to support all stages of development and manufacturing - Record of success in helping clients bring new products to market quickly and efficiently - We have a team of 200+ scientists, 500+ pilot and commercial scale facilities, and EU and US compliance. We offer the following services: * Cell culture * Media development * Antibody production * Bioprocess development * cGMP manufacturing * Analytical testing and QC * Fill and finish * And more! To learn more about what WELLBIOTEC can do for your program, please visit our website at www.wellbiotec.co.kr or email info@wellbiotec.co.kr
Address:

5/F Gyeongjin Bldg. 17 Yeongdong-daero 106-gil

Gangnam-gu Seoul

Seoul

06170 Republic Of Korea

Revenue
Company is likely to sell
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.